# Phase 2 Post-Checkpoint Roadmap Amendment

```text
PHASE COVERAGE: 2 OF 3
PROJECT CHAT COVERAGE: PARTIAL
GLOBAL RECONCILIATION: NOT COMPLETE
GLOBAL AUDIT: NOT COMPLETE
CODEX-READY GLOBAL BASELINE: NOT ESTABLISHED
```

Date: 2026-08-12

This is a bounded amendment after the Phase 2 checkpoint. It records an explicit user-directed change to the canonical Project representation of the existing oxygen-transport renderer PR. It does not reopen Phase 3 or authorize production merge, deployment, clinical validation, independent QA closure, or release.

## Change applied

- Production PR: [#3 - M1-Batch 6 Three.js oxygen transport renderer and free anatomy integration](https://github.com/R3C4LL4L1F3/RT-study-lab/pull/3).
- Canonical Project: [RT Study Lab - Development Roadmap & Control](https://github.com/users/R3C4LL4L1F3/projects/1).
- Project item: **#18**.
- Membership: verified present.
- Status: **IN PROGRESS**.
- Workstream / Project Area: **Interactive Models**.
- Active Development view: verified; the status filter shows this renderer item as the matching item.
- Current Project surface after amendment: **18 items, 13 named views, 5 enabled workflows**.

## Authority reconciliation

The user explicitly requested that the existing renderer PR be represented on the roadmap and marked IN PROGRESS. That Project state records active implementation activity. It does not supersede Issue #9, which remains the canonical architecture/model-contract gate and still states **APPROVED FOR SPECIFICATION - IMPLEMENTATION NOT APPROVED**.

The following remain open and unchanged:

- architecture/model-contract approval under Issue #9;
- clinical/model specification and evidence boundaries;
- asset provenance review;
- independent QA and visual/educational validation;
- release-gate disposition;
- merge and deployment correspondence.

Priority, risk, owner, release, clinical, architecture, and QA fields were not changed because the user requested the roadmap membership and status transition, not a new gate or risk disposition. No duplicate Issue #9 or new defect item was created.

## Current evidence

- PR #3 remains draft/open, with 12 commits, 55 changed files, one successful check, and no completed review approval.
- The renderer implementation is not on verified production `main` `d64bde34b69a73c2f71f5a7f5863eca4b5bdbdf6`.
- The renderer PR activity confirms it was previously added, moved to IN PROGRESS, and later removed from the Project; the current membership is the explicit re-addition recorded here.
- Issue #9 remains open and its implementation gate wording was not changed.

## Interpretation boundary

`IN PROGRESS` is a roadmap/work-state representation only. It must not be read as implementation approval, clinical correctness, independent QA PASS, release readiness, merge authorization, or live deployment equivalence.

The original Phase 2 manifest and checkpoint retain their report-time count of 17 items before this later amendment. This amendment is the current durable record for the post-checkpoint Project state of item #18.
